Extraesophageal Manifestations of Gastroesophageal Reflux Disease

Gastroenterology Clinics of North America

Volumn 42, Issue 1, 2013, Pages 71-91

  Hom, Christopher ^a   Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Asthma; Chronic cough; Chronic laryngitis; Extraesophageal reflux syndrome; Laryngopharyngeal reflux

Indexed keywords

AMITRIPTYLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GABAPENTIN; OMEPRAZOLE; PEPSIN A; PLACEBO; PREGABALIN; PROTON PUMP INHIBITOR; RANITIDINE; SALBUTAMOL;

ASTHMA; BRONCHITIS; CHRONIC COUGH; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL (TOPIC); COUGHING; EAR DISEASE; ESOPHAGEAL PH MONITORING; ESOPHAGOGASTRODUODENOSCOPY; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; LUNG DISEASE; META ANALYSIS (TOPIC); NOSE DISEASE; OFF LABEL DRUG USE; PH MEASUREMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH FUNDOPLICATION; THROAT DISEASE;

ASTHMA; COUGH; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; SYNDROME;

EID: 84875291361     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2012.11.004     Document Type: Review

References (113)

1. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101:1900-1920. [quiz: 1943].
2. Berstad T. Gastro-oesophageal reflux and chronic respiratory disease in infants and children: surgical treatment. Scand J Gastroenterol Suppl 1995, 211:26-28.
3. Cicala M., Emerenziani S., Caviglia R., et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003, 18:605-613.
4. Napierkowski J., Wong R.K. Extraesophageal manifestations of GERD. Am J Med Sci 2003, 326:285-299.
5. Shaw G.Y. Application of ambulatory 24-hour multiprobe pH monitoring in the presence of extraesophageal manifestations of gastroesophageal reflux. Ann Otol Rhinol Laryngol Suppl 2000, 184:15-17.
6. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999, 231:29-37.
7. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005, 54:710-717.
8. Bor S., Mandiracioglu A., Kitapcioglu G., et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol 2005, 100:759-765.
9. Fenter T.C., Naslund M.J., Shah M.B., et al. The cost of treating the 10 most prevalent diseases in men 50 years of age or older. Am J Manag Care 2006, 12:S90-S98.
10. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122:1500-1511.
11. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009, 136:376-386.
12. Jaspersen D. Extra-esophageal disorders in gastroesophageal reflux disease. Dig Dis 2004, 22:115-119.
13. Malagelada J.R. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004, 19(Suppl 1):43-48.
14. DeVault K.R. Extraesophageal symptoms of GERD. Cleve Clin J Med 2003, 70(Suppl 5):S20-S32.
15. Paterson W.G. Extraesophageal complications of gastroesophageal reflux disease. Can J Gastroenterol 1997, 11(Suppl B):45B-50B.
16. Paterson W.G. Extraesophageal manifestations of reflux disease: myths and reality. Chest Surg Clin N Am 2001, 11:523-538.
17. Field S.K., Evans J.A., Price L.M. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med 1998, 157:1058-1062.
18. Ing A.J., Ngu M.C., Breslin A.B. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 1994, 149:160-167.
19. Adhami T., Goldblum J.R., Richter J.E., et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004, 99:2098-2106.
20. Tuchman D.N., Boyle J.T., Pack A.I., et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984, 87:872-881.
21. Tokayer A.Z. Gastroesophageal reflux disease and chronic cough. Lung 2008, 186(Suppl 1):S29-S34.
22. Shaker R. Protective mechanisms against supraesophageal GERD. J Clin Gastroenterol 2000, 30:S3-S8.
23. Jadcherla S.R., Gupta A., Coley B.D., et al. Esophago-glottal closure reflex in human infants: a novel reflex elicited with concurrent manometry and ultrasonography. Am J Gastroenterol 2007, 102:2286-2293.
24. Vakil N.B., Kahrilas P.J., Dodds W.J., et al. Absence of an upper esophageal sphincter response to acid reflux. Am J Gastroenterol 1989, 84:606-610.
25. Wright R.A., Miller S.A., Corsello B.F. Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology 1990, 99:71-73.
26. Poe R.H., Kallay M.C. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003, 123:679-684.
27. Irwin R.S. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 2006, 129:80S-94S.
28. Kahrilas P.J., Lee T.J. Pathophysiology of gastroesophageal reflux disease. Thorac Surg Clin 2005, 15:323-333.
29. Chang A.B., Lasserson T.J., Gaffney J., et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2005, (2). CD004823.
30. Sontag S.J. The spectrum of pulmonary symptoms due to gastroesophageal reflux. Thorac Surg Clin 2005, 15:353-368.
31. Hadjiliadis D., Duane Davis R., Steele M.P., et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003, 17:363-368.
32. Ours T.M., Kavuru M.S., Schilz R.J., et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999, 94:3131-3138.
33. Baldi F., Cappiello R., Cavoli C., et al. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol 2006, 12:82-88.
34. Gislason T., Janson C., Vermeire P., et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest 2002, 121:158-163.
35. el-Serag H.B., Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997, 113:755-760.
36. Poelmans J., Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut 2005, 54:1492-1499.
37. Ludviksdottir D., Bjornsson E., Janson C., et al. Habitual coughing and its associations with asthma, anxiety, and gastroesophageal reflux. Chest 1996, 109:1262-1268.
38. Alhabib K.F., Vedal S., Champion P., et al. The utility of ambulatory pH monitoring in patients presenting with chronic cough and asthma. Can J Gastroenterol 2007, 21:159-163.
39. Everett C.F., Morice A.H. Clinical history in gastroesophageal cough. Respir Med 2007, 101:345-348.
40. Laukka M.A., Cameron A.J., Schei A.J. Gastroesophageal reflux and chronic cough: which comes first?. J Clin Gastroenterol 1994, 19:100-104.
41. Slaughter J.C., Goutte M., Rymer J.A., et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011, 9:868-874.
42. Kavitt R.T., Higginbotham T., Slaughter J.C., et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol 2012, 107:1826-1832.
43. Smith J.A., Decalmer S., Kelsall A., et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 2010, 139:754-762.
44. Faruqi S., Molyneux I.D., Fathi H., et al. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology 2011, 16:1150-1156.
45. Shaheen N.J., Crockett S.D., Bright S.D., et al. Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011, 33:225-234.
46. Francis D.O., Slaughter J.C., Choksi Y., et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol 2012, [in review], in press.
47. Francis D.O., Goutte M., Slaughter J.C., et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope 2011, 121:1902-1909.
48. Bastian R.W., Vaidya A.M., Delsupehe K.G. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg 2006, 135:17-21.
49. O'Connell F., Thomas V.E., Pride N.B., et al. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med 1994, 150:374-380.
50. Lee B., Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol 2005, 114:253-257.
51. Mintz S., Lee J.K. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med 2006, 119:e13-e15.
52. Ryan N.M., Birring S.S., Gibson P.G. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012, 380:1583-1589.
53. Halum S.L., Sycamore D.L., McRae B.R. A new treatment option for laryngeal sensory neuropathy. Laryngoscope 2009, 119:1844-1847.
54. Harding S.M., Guzzo M.R., Richter J.E. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999, 115:654-659.
55. Sontag S.J., O'Connell S., Khandelwal S., et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990, 99:613-620.
56. Harding S.M., Guzzo M.R., Richter J.E. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000, 162:34-39.
57. Thomas J.W. National Heart, Lung, and Blood Institute resources and programs for cell-based therapies. Circ Res 2007, 101:1-6.
58. Parsons J.P., Mastronarde J.G. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med 2010, 16:60-63.
59. Choy D., Leung R. Gastro-oesophageal reflux disease and asthma. Respirology 1997, 2:163-168.
60. Zerbib F., Guisset O., Lamouliatte H., et al. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med 2002, 166:1206-1211.
61. Havemann B.D., Henderson C.A., El-Serag H.B. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007, 56:1654-1664.
62. Kiljander T.O., Salomaa E.R., Hietanen E.K., et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest 1999, 116:1257-1264.
63. Meier J.H., McNally P.R., Punja M., et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 1994, 39:2127-2133.
64. Leggett J.J., Johnston B.T., Mills M., et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest 2005, 127:1227-1231.
65. Sontag S.J., O'Connell S., Khandelwal S., et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003, 98:987-999.
66. Littner M.R., Leung F.W., Ballard E.D., et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005, 128:1128-1135.
67. Mastronarde J.G., Anthonisen N.R., Castro M., et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009, 360:1487-1499.
68. Holbrook J.T., Wise R.A., Gold B.D., et al. Lansoprazole for children with poorly controlled asthma a randomized controlled trial. JAMA 2012, 307:373-381.
69. Gibson P.G., Powell H., Coughlan J., et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2002, (2). CD001005.
70. Kiljander T.O., Harding S.M., Field S.K., et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006, 173:1091-1097.
71. Locke G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1448-1456.
72. Agreus L., Svardsudd K., Talley N.J., et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001, 96:2905-2914.
73. Wo J.M., Grist W.J., Gussack G., et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol 1997, 92:2160-2165.
74. Vaezi M.F. Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests?. Am J Gastroenterol 2004, 99:786-788.
75. Metz D.C., Childs M.L., Ruiz C., et al. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997, 116:41-46.
76. Diamond L. Laryngopharyngeal reflux-it's not GERD. JAAPA 2005, 18:50-53.
77. Samuels T.L., Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg 2009, 141:559-563.
78. Johnston N., Dettmar P.W., Bishwokarma B., et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 2007, 117:1036-1039.
79. Wood J.M., Hussey D.J., Woods C.M., et al. Biomarkers and laryngopharyngeal reflux. J Laryngol Otol 2011, 125:1218-1224.
80. Johnston N., Wells C.W., Blumin J.H., et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol 2007, 116:934-938.
81. Vaezi M.F., Slaughter J.C., Smith B.S., et al. Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Aliment Pharmacol Ther 2010, 32:916-924.
82. Kendall K.A. Controversies in the diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg 2006, 14:113-115.
83. Hicks D.M., Ours T.M., Abelson T.I., et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002, 16:564-579.
84. Milstein C.F., Charbel S., Hicks D.M., et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 2005, 115:2256-2261.
85. Vavricka S.R., Storck C.A., Wildi S.M., et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol 2007, 102:716-722.
86. Vaezi M.F. Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone 2003, 5:32-38. [discussion:39-40].
87. Joniau S., Bradshaw A., Esterman A., et al. Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg 2007, 136:686-692.
88. Johnson D.A. Medical therapy of reflux laryngitis. J Clin Gastroenterol 2008, 42:589-593.
89. Vaezi M.F., Hicks D.M., Abelson T.I., et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 2003, 1:333-344.
90. Tutuian R., Castell D.O. Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med 2003, 115(Suppl 3A):119S-123S.
91. Vaezi M.F., Schroeder P.L., Richter J.E. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol 1997, 92:825-829.
92. Carroll T.L., Fedore L.W., Aldahlawi M.M. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope 2012, 122:2473-2481.
93. Becker V., Bajbouj M., Waller K., et al. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther 2007, 26:1355-1360.
94. Iwakiri K., Kawami N., Sano H., et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol 2009, 44:708-712.
95. Mainie I., Tutuian R., Agrawal A., et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006, 93:1483-1487.
96. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006, 55:1398-1402.
97. Vaezi M.F., Hicks D.M., Ours T.M., et al. ENT manifestation of GERD: a large prospective study assessing treatment outcome and predictors of response. Gastroenterology 2001, 120:A636.
98. Vaezi M.F. Laryngitis: from the gastroenterologist's point of view. Extraesophageal reflux 2009, 37-47. Plural Publishing, Inc., San Diego (CA). M.F. Vaezi (Ed.).
99. Pritchett J.M., Aslam M., Slaughter J.C., et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009, 7:743-748.
100. Fletcher K.C., Slaughter J.C., Garrett C.G., et al. Significance and degree of reflux in patients with primary extraesophageal symptoms. Laryngoscope 2011, 121:2561-2565.
101. Wiener G.J., Tsukashima R., Kelly C., et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 2009, 23:498-504.
102. Sun G., Muddana S., Slaughter J.C., et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope 2009, 119:1639-1643.
103. Yuksel E.S., Slaughter J.C., Mucktar N., et al. In vitro and in vivo studies with a novel oropharyngeal pH monitoring device implicates utility in chronic laryngitis. Clin Gastroenterol Hepatol 2012, [in review].
104. Potluri S., Friedenberg F., Parkman H.P., et al. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung. Dig Dis Sci 2003, 48:1813-1817.
105. Piper D.W., Fenton B.H. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut 1965, 6:506-508.
106. Ozmen S., Yucel O.T., Sinici I., et al. Nasal pepsin assay and pH monitoring in chronic rhinosinusitis. Laryngoscope 2008, 118:890-894.
107. Printza A., Speletas M., Triaridis S., et al. Is pepsin detected in the saliva of patients who experience pharyngeal reflux?. Hippokratia 2007, 11:145-149.
108. Kim T.H., Lee K.J., Yeo M., et al. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion 2008, 77:201-206.
109. Strugala V.M., Watson M.G., Morice A.H., et al. Detection of pepsin using a non-invasive lateral flow test for the diagnosis of extra-esophageal reflux - results of a pilot study. Gut 2007, 56:A212.
110. Yuksel E.S., Strugala V., Slaughter J.C., et al. Rapid salivary pepsin test: blinded assessment of test performance in GERD. Laryngoscope 2012, 122:1312-1316.
111. Vaezi M.F., Richter J.E., Stasney C.R., et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006, 116:254-260.
112. Qadeer M.A., Phillips C.O., Lopez A.R., et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006, 101:2646-2654.
113. Patel S.M., Stason W.B., Legedza A., et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005, 17:332-340.